Medirita
Seoul, KR· latest recorded location
MEDIRITA is named on 1 US grants and 6 published applications in this corpus. Its most frequent classification is G16C (Computational chemistry).
- Granted patents
- 1
- Published applications
- 6
- Inventors
- 2
- Granted in 2026 so far
- 0
- Most recent grant
- 27 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 4 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year.
Technology areas
Share of 7 documents
- G16CComputational chemistry7
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or5
- G06FComputing and data processing4
- G06NAI and machine learning4
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the4
Recent patents
- Method for predicting pharmacological effects of new drug candidate substance based on artificial intelligence24 Oct 2024US 2024/0355430 A1
- Method for data processing to derive new drug candidate substance20 Jan 2022US 2022/0020454 A1
- Apparatus and method for processing data discovering new drug candidate substance23 Dec 2021US 2021/0397978 A1
- Apparatus and method for processing multi-omics data for discovering new drug candidate substance23 Dec 2021US 2021/0398688 A1
- Method and apparatus for deriving new drug candidate substance25 Nov 2021US 2021/0365795 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.